Clinical Trials Browser

Phase 1/2 × Lymphoma, Large B-Cell, Diffuse × carfilzomib × Clear all

NCT02073097 2024-05-29

Carfilzomib, Rituximab, and Combination Chemotherapy in Treating Patients With Diffuse Large B-Cell Lymphoma

Phase 1/2 Completed

48 enrolled 18 charts

Lymphoma, Large B-Cell, Diffuse